Both Eli Lilly $LLY (-2.32%) and Novo Nordisk $NVO (-0.97%) are disrupting the diet industry with their GLP-1 drugs, offering the potential for significant growth in the future.

$LLY (-2.32%) is on track to become the first trillion dollar drug-maker...😯